Glaukos Investor Relations Material
Latest events
AGM 2024
Glaukos
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Glaukos Corporation
Access all reports
Glaukos Corporation is a clinical-stage medical device company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment and management of glaucoma, corneal disorders and retinal diseases.
Key slides for Glaukos Corporation
Investor Presentation
Glaukos Corporation
J.P. Morgan 42nd Annual Healthcare Conference 2024
Glaukos Corporation
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
GKOS
Country
🇺🇸 United States